New bowel cancer test shows greater than 90% accuracy in high-risk patients
New bowel cancer test shows greater than 90% accuracy in high-risk patients
Share:
A new method for detecting bowel cancer is more than 90% accurate at predicting which higher risk people will develop the disease, research has shown. People with inflammatory bowel disease (IBD), such as Crohn’s and ulcerative colitis, are known to have an increased chance of bowel cancer, but not all will develop it.
Now, a study, funded by Cancer Research UK, has shown more than 90% accuracy in predicting bowel cancer risk in the next five years in a high-risk group of people with IBD. This could lead to a blood test which will inform doctors which IBD patients are most at risk of bowel cancer.
We can accurately identify those people at high risk whilst putting the minds of many others at rest. Professor Trevor Graham, from the Institute of Cancer Research (ICR), which co-led the research, said: “Most people with ulcerative colitis or Crohn’s disease won’t develop bowel cancer.
“But for those that have these conditions and are showing signs of pre-cancer in their colon, there are some tough decisions to make. “Either they have it monitored regularly, in the hope that it doesn’t become cancer, or they have their bowel removed to guarantee they don’t get cancer in the future. Neither of these options are particularly pleasant.
“Our test and algorithm give people with IBD, and the doctors who care for them, the best possible information so that they can make the right decision about how to manage their cancer risk. “We can accurately identify those people at high risk whilst putting the minds of many others at rest.”.
Share:
More for You
Top Followed
You Might Also Like
